Version: 1.0.0 | Published: 24 Mar 2026 | Updated: 35 days ago
Summary
Description:
CPRD GOLD linked Systemic Anti-Cancer Treatment (SACT) data contain chemotherapy treatment details, including regime and outcomes, for solid tumour and haematological malignancies treated in England.
Identifier:
10.48329/4jwp-4951
Contact Point:
Health Theme:
Cancer
Health Category:
Electronic Health Records (EHRs)
Number of Unique Individuals:
901965
Documentation
Associated Media:
Documentation:
CPRD GOLD linked Systemic Anti-Cancer Treatment (SACT) data covers chemotherapy treatment for all solid tumour and haematological malignancies, including those in clinical trials. Information is included about programme and regime of treatment, and the outcome for each treatment.
Coverage
Spatial
Spatial Coverage:
- United Kingdom
- England
Temporal
Start Date:
01 January 2014
End Date:
31 December 2018
Frequency:
QUARTERLY
Date of Latest Release:
05 September 2021
Date of First Release:
08 October 2024
Temporal Aggregation:
1 - 10 Years
Provenance
Origin
Collection Situation:
- Clinic
- Community
- Secondary care - In-patients
- Secondary care - Outpatients
Image Contrast:
Not stated
Method of Collection:
EPR
Access and Governance
Usage
Data Use Requirements:
- Project specific restriction
- Geographical restriction
- User specific restriction
- Time limit on use
- Institution specific restriction
Access
Access Rights:
Jurisdiction:
England
Data Controller:
Clinical Practice Research Datalink (CPRD)
Data Processor:
CPRD
Delivery Lead Time:
Variable
Legal Basis:
General research use, No linkage, Research-specific restrictions, Research use
only
Health Data Access Body:
Public Health England (PHE) via the National Cancer Registration and Analysis
Service (NCRAS)
Format and Standards
Language:
English
Format:
Tab delimited text
Coding System:
- ICD10
- ICDO3
- OPCS4
Data Distribution
Data Status:
Not available
Distribution:
Access to CPRD data, including UK Primary Care Data, and linked data such as
Hospital Episode Statistics, is subject to protocol approval via CPRD’s Research
Data Governance (RDG) Process. Independent scientific and patient advice is
provided by Expert Review Committees (ERCs) and the Central Advisory Committee
(CAC): https://www.cprd.com/research-applications, https://www.cprd.com/pricing
Observations
Name
Population Type
Value
Description
Variable Measured
Unit Code
Observation Date
Number of Records
Minimum Typical Age
Maximum Typical Age
Persons
901965
Number of CPRD GOLD patients matched to a single cancer identifier
Count
05 September 2021
901965
0
115
Origin
Name:
Data Catalogue